TARS - Tarsus Pharmaceuticals Inc
IEX Last Trade
27.05
-0.550 -2.033%
Share volume: 636,703
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$27.60
-0.55
-1.99%
Summary score
24%
Profitability
25%
Dept financing
6%
Liquidity
75%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-10.03%
Return on assets
-8.33%
Return on sales
-1176.8%
Return on invested capital
140.93%
Total debt ratio
14.66%
Debt ratio change over timeo
-0.93%
Current Ratio
14.79%
Quick Ratio
14.78%
Cash Position Ratio
13.91%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-18.46%
Return on assets
-15.04%
Return on sales
-888.09%
Return on invested capital
217.58%
Total debt ratio
22.3%
Debt ratio change over timeo
-0.93%
Current Ratio
9.63%
Quick Ratio
9.59%
Cash Position Ratio
8.97%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-12.98%
Return on assets
-10.79%
Return on sales
-136.47%
Return on invested capital
105.17%
Total debt ratio
21.21%
Debt ratio change over time
-0.86%
Current Ratio
8.01%
Quick Ratio
7.92%
Cash Position Ratio
7.02%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-105.81%
Return on assets
-104.91%
Return on sales
-1028.44%
Return on invested capital
-17.98%
Total debt ratio
-92.85%
Debt ratio change over time
-0.93%
Current Ratio
4.43%
Quick Ratio
4.41%
Cash Position Ratio
4.43%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TARS | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -10.03% | 18.83% | 17.34% | 7.6% |
| Return on assets | -8.33% | 4.16% | 8.21% | 3.22% |
| Return on sales | -1176.8% | 28.21% | 41.18% | 25.37% |
| Return on invested capital | 140.93% | 9.79% | -219.55% | 7.46% |
| Profitability | 25% | 57% | 73% | 37% |
| Total debt ratio | 14.66% | 82.89% | 55.88% | 60.02% |
| Debt ratio change over time | -0.93% | -4.38% | -0.73% | -33.74% |
| Dept financing | 4% | 25% | 42% | 18% |
| Current Ratio | 9.63% | 1.12% | 0% | 1.16% |
| Quick Ratio | 9.59% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 8.97% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 4% | 4% | 5% |
| Short-term ratios | TARS | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -18.46% | 13.31% | 0% | 13.48% |
| Return on assets | -15.04% | 4.72% | 0% | 3.05% |
| Return on sales | -888.09% | 31.4% | 0% | 25.56% |
| Return on invested capital | 217.58% | 10.68% | 0% | 13.96% |
| Profitability | 25% | 76% | 0% | 63% |
| Total debt ratio | 22.3% | 80.89% | 0% | 59.04% |
| Debt ratio change over time | -0.93% | -41.82% | 0% | 7.13% |
| Dept financing | 7% | 25% | 0% | 43% |
| Current Ratio | 9.63% | 1.12% | 0% | 1.16% |
| Quick Ratio | 9.59% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 8.97% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 6% | 0% | 7% |